scholarly journals Esophageal pressures in acute lung injury: do they represent artifact or useful information about transpulmonary pressure, chest wall mechanics, and lung stress?

2010 ◽  
Vol 108 (3) ◽  
pp. 515-522 ◽  
Author(s):  
Stephen H. Loring ◽  
Carl R. O'Donnell ◽  
Negin Behazin ◽  
Atul Malhotra ◽  
Todd Sarge ◽  
...  

Acute lung injury can be worsened by inappropriate mechanical ventilation, and numerous experimental studies suggest that ventilator-induced lung injury is increased by excessive lung inflation at end inspiration or inadequate lung inflation at end expiration. Lung inflation depends not only on airway pressures from the ventilator but, also, pleural pressure within the chest wall. Although esophageal pressure (Pes) measurements are often used to estimate pleural pressures in healthy subjects and patients, they are widely mistrusted and rarely used in critical illness. To assess the credibility of Pes as an estimate of pleural pressure in critically ill patients, we compared Pes measurements in 48 patients with acute lung injury with simultaneously measured gastric and bladder pressures (Pga and Pblad). End-expiratory Pes, Pga, and Pblad were high and varied widely among patients, averaging 18.6 ± 4.7, 18.4 ± 5.6, and 19.3 ± 7.8 cmH2O, respectively (mean ± SD). End-expiratory Pes was correlated with Pga ( P = 0.0004) and Pblad ( P = 0.0104) and unrelated to chest wall compliance. Pes-Pga differences were consistent with expected gravitational pressure gradients and transdiaphragmatic pressures. Transpulmonary pressure (airway pressure − Pes) was −2.8 ± 4.9 cmH2O at end exhalation and 8.3 ± 6.2 cmH2O at end inflation, values consistent with effects of mediastinal weight, gravitational gradients in pleural pressure, and airway closure at end exhalation. Lung parenchymal stress measured directly as end-inspiratory transpulmonary pressure was much less than stress inferred from the plateau airway pressures and lung and chest wall compliances. We suggest that Pes can be used to estimate transpulmonary pressures that are consistent with known physiology and can provide meaningful information, otherwise unavailable, in critically ill patients.

2017 ◽  
Vol 2 (2) ◽  
pp. 1-12 ◽  
Author(s):  
Ruxana T. Sadikot ◽  
Arun V. Kolanjiyil ◽  
Clement Kleinstreuer ◽  
Israel Rubinstein

Acute lung injury and acute respiratory distress syndrome (ARDS) represent a heterogenous group of lung disease in critically ill patients that continues to have high mortality. Despite the increased understanding of the molecular pathogenesis of ARDS, specific targeted treatments for ARDS have yet to be developed. ARDS represents an unmet medical need with an urgency to develop effective pharmacotherapies. Multiple promising targets have been identified that could lead to the development of potential therapies for ARDS; however, they have been limited because of difficulty with the mode of delivery, especially in critically ill patients. Nanobiotechnology is the basis of innovative techniques to deliver drugs targeted to the site of inflamed organs, such as the lungs. Nanoscale drug delivery systems have the ability to improve the pharmacokinetics and pharmacodynamics of agents, allowing an increase in the biodistribution of therapeutic agents to target organs and resulting in improved efficacy with reduction in drug toxicity. Although attractive, delivering nanomedicine to lungs can be challenging as it requires sophisticated systems. Here we review the potential of novel nanomedicine approaches that may prove to be therapeutically beneficial for the treatment of this devastating condition.


2013 ◽  
Vol 187 (7) ◽  
pp. 736-742 ◽  
Author(s):  
Ashish Agrawal ◽  
Michael A. Matthay ◽  
Kirsten N. Kangelaris ◽  
John Stein ◽  
Jeffrey C. Chu ◽  
...  

Transfusion ◽  
2006 ◽  
Vol 46 (9) ◽  
pp. 1478-1483 ◽  
Author(s):  
Rimki Rana ◽  
Evans R. Fernandez-Perez ◽  
S. Anjum Khan ◽  
Sameer Rana ◽  
Jeffrey L. Winters ◽  
...  

Anaesthesia ◽  
2012 ◽  
Vol 67 (6) ◽  
pp. 594-599 ◽  
Author(s):  
P. R. Tuinman ◽  
A. P. Vlaar ◽  
J. M. Binnenkade ◽  
N. P. Juffermans

Medicine ◽  
2018 ◽  
Vol 97 (10) ◽  
pp. e9929 ◽  
Author(s):  
John Rene Labib ◽  
Sally Kamal Ibrahem ◽  
Hala Mohamed Sleem ◽  
Mohamed M. Ismail ◽  
Shaimaa A.M. Abd El Fatah ◽  
...  

Shock ◽  
2019 ◽  
Vol 52 (3) ◽  
pp. 370-377 ◽  
Author(s):  
Freja Stæhr Holm ◽  
Pradeesh Sivapalan ◽  
Niels Seersholm ◽  
Theis Skovsgaard Itenov ◽  
Per Hjort Christensen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document